PL2814812T3 - Sposób wytwarzania związków sulfiliminowych - Google Patents

Sposób wytwarzania związków sulfiliminowych

Info

Publication number
PL2814812T3
PL2814812T3 PL13748778T PL13748778T PL2814812T3 PL 2814812 T3 PL2814812 T3 PL 2814812T3 PL 13748778 T PL13748778 T PL 13748778T PL 13748778 T PL13748778 T PL 13748778T PL 2814812 T3 PL2814812 T3 PL 2814812T3
Authority
PL
Poland
Prior art keywords
methods
producing
sulfilimine compounds
compounds
producing sulfilimine
Prior art date
Application number
PL13748778T
Other languages
English (en)
Inventor
Timothy J Adaway
Original Assignee
Dow Agrosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Agrosciences Llc filed Critical Dow Agrosciences Llc
Publication of PL2814812T3 publication Critical patent/PL2814812T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
PL13748778T 2012-02-16 2013-02-15 Sposób wytwarzania związków sulfiliminowych PL2814812T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261599489P 2012-02-16 2012-02-16
EP13748778.1A EP2814812B1 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds
PCT/US2013/026377 WO2013123349A1 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds

Publications (1)

Publication Number Publication Date
PL2814812T3 true PL2814812T3 (pl) 2017-10-31

Family

ID=48982761

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13748778T PL2814812T3 (pl) 2012-02-16 2013-02-15 Sposób wytwarzania związków sulfiliminowych

Country Status (19)

Country Link
US (2) US9227936B2 (pl)
EP (1) EP2814812B1 (pl)
JP (1) JP6138834B2 (pl)
KR (1) KR102064827B1 (pl)
CN (1) CN104271555B (pl)
AR (1) AR090076A1 (pl)
AU (1) AU2013221420B2 (pl)
BR (1) BR102013003576B8 (pl)
CA (1) CA2863994C (pl)
CO (1) CO7081159A2 (pl)
ES (1) ES2625106T3 (pl)
IL (1) IL233956B (pl)
IN (1) IN2014DN07442A (pl)
MX (1) MX368125B (pl)
PL (1) PL2814812T3 (pl)
RU (1) RU2634718C2 (pl)
UA (1) UA116628C2 (pl)
WO (1) WO2013123349A1 (pl)
ZA (1) ZA201406494B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105324365A (zh) * 2012-12-11 2016-02-10 美国陶氏益农公司 用于制备n-氰基-s-[1-(吡啶-3-基)乙基]-s-甲基硫亚胺的改善方法
CA2942387A1 (en) 2014-03-13 2015-09-17 Proteostasis Therapeutics, Inc. Compounds, compositions and methods of increasing cftr actvity
AU2015229188A1 (en) 2014-03-13 2016-09-29 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
EP3157917B1 (en) 2014-06-19 2020-03-18 Proteostasis Therapeutics, Inc. Compounds, compositions and methods of increasing cftr activity
CA2971850A1 (en) 2014-12-23 2016-06-30 Proteostasis Therapeutics, Inc. Derivatives of 5-phenyl- or 5-heteroarylthiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
MA41253A (fr) 2014-12-23 2017-10-31 Proteostasis Therapeutics Inc Composés, compositions et procédés pour augmenter l'activité du cftr
WO2016105468A1 (en) 2014-12-23 2016-06-30 Proteostasis Therapeutics, Inc. Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
WO2016105484A1 (en) 2014-12-23 2016-06-30 Proteostasis Therapeutics, Inc. Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
US10548878B2 (en) 2015-07-24 2020-02-04 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods of increasing CFTR activity
WO2017062581A1 (en) 2015-10-06 2017-04-13 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for modulating cftr
US10662207B2 (en) 2016-04-07 2020-05-26 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for modulating CFTR
TWI735573B (zh) * 2016-06-21 2021-08-11 美商陶氏農業科學公司 生產某些經取代硫亞胺之方法
US10899751B2 (en) 2016-06-21 2021-01-26 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
GB201905721D0 (en) 2019-04-24 2019-06-05 Univ Dundee Compounds
CN121548569A (zh) 2023-07-18 2026-02-17 安道麦马克西姆有限公司 用于制备n-氰基硫亚胺化合物的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2573733A (en) * 1950-01-03 1951-11-06 Celanese Corp Production of anthraquinone dyestuffs
US4085093A (en) 1976-07-23 1978-04-18 The Goodyear Tire & Rubber Company Sulfilimines as premature vulcanization inhibitors
FR2723370B1 (fr) * 1994-08-02 1996-09-13 Roussel Uclaf Nouveaux derives de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
AR015104A1 (es) * 1996-11-13 2001-04-18 Dowelanco Compuestos de n-arilsulfilimina sustituidos, utiles como catalizadores en la preparacion de compuestos de n-arilarilsulfonamida; proceso para preparar dichos compuestos y su uso para catalizar dicha preparacion.
ES2611018T3 (es) * 2004-04-08 2017-05-04 Dow Agrosciences Llc Sulfoximinas N-sustituidas insecticidas
TWI387585B (zh) * 2006-09-01 2013-03-01 Dow Agrosciences Llc 殺蟲性之n-取代(雜芳基)烷基烴基硫亞胺
TWI383970B (zh) * 2006-11-08 2013-02-01 Dow Agrosciences Llc 多取代的吡啶基磺醯亞胺及其作為殺蟲劑之用途
AU2008219748B2 (en) * 2007-02-26 2012-05-03 Corteva Agriscience Llc Process for the preparation of certain substituted sulfilimines
BRPI0811172B1 (pt) * 2007-05-01 2018-01-02 Dow Agrosciences Llc "composição pesticida sinergísta,e processo para sua aplicação".
US20090023782A1 (en) * 2007-07-20 2009-01-22 Dow Agrosciences Llc Increasing plant vigor
AU2010288534A1 (en) * 2009-08-26 2012-03-15 Novartis Ag Tetra-substituted heteroaryl compounds and their use as MDM2 and/or MDM4 modulators
CN105324365A (zh) * 2012-12-11 2016-02-10 美国陶氏益农公司 用于制备n-氰基-s-[1-(吡啶-3-基)乙基]-s-甲基硫亚胺的改善方法

Also Published As

Publication number Publication date
CN104271555B (zh) 2017-06-06
US9227936B2 (en) 2016-01-05
UA116628C2 (uk) 2018-04-25
BR102013003576A2 (pt) 2015-06-16
RU2014137257A (ru) 2016-04-10
US9884824B2 (en) 2018-02-06
IN2014DN07442A (pl) 2015-04-24
EP2814812A1 (en) 2014-12-24
ES2625106T3 (es) 2017-07-18
JP2015507018A (ja) 2015-03-05
MX368125B (es) 2019-09-19
AU2013221420B2 (en) 2017-07-13
US20160046580A1 (en) 2016-02-18
IL233956B (en) 2018-08-30
EP2814812A4 (en) 2015-07-01
AU2013221420A1 (en) 2014-09-25
ZA201406494B (en) 2016-12-21
BR102013003576B1 (pt) 2019-09-17
EP2814812B1 (en) 2017-03-29
CN104271555A (zh) 2015-01-07
KR102064827B1 (ko) 2020-01-13
BR102013003576B8 (pt) 2022-10-11
IL233956A0 (en) 2014-09-30
WO2013123349A1 (en) 2013-08-22
MX2014009922A (es) 2014-11-21
AR090076A1 (es) 2014-10-15
CA2863994C (en) 2020-06-16
RU2634718C2 (ru) 2017-11-03
KR20140127320A (ko) 2014-11-03
CO7081159A2 (es) 2014-10-10
CA2863994A1 (en) 2013-08-22
JP6138834B2 (ja) 2017-05-31
US20130217883A1 (en) 2013-08-22

Similar Documents

Publication Publication Date Title
ZA201406494B (en) Methods of producing sulfilimine compounds
PL2825719T3 (pl) Sposób obsługi odwiertów
SG11201405573WA (en) Production of graphene
PL2836460T3 (pl) Sposób wytwarzania grafenu
ZA201500701B (en) Process for the preparation of 4-amino-5-fluoro-3-halo-6-(substituted)picolinates
PL2931937T3 (pl) Sposób wytwarzania układów nanocząstek metali
EP2800747A4 (en) POLYMORPHY OF PERAMPANEL
IL231834A0 (en) An improved method for the production of macrochroses
ZA201504166B (en) Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates
GB201220155D0 (en) Method of manufacture
IL237862A0 (en) Methods to reduce the formation of scale
ZA201504165B (en) Process for the preparation of 4-amino-5-fluoro-3-chloro-6-(substituted)picolinates
ZA201405321B (en) Methods of ganglioside production
ZA201502350B (en) Solid form of hihydro-pyrido-oxazine derivative
GB201215942D0 (en) Method of treatent
SG2013085071A (en) Method of producing methionine
PL2852513T3 (pl) Sposób wytwarzania podzespołów
IL241475A0 (en) method for synthesis
EP2817294A4 (en) PROCESS FOR THE PREPARATION OF DFMB DERIVATIVES
HUE036665T2 (hu) Dihidro-pirido-oxazin származék szilárd formái
GB201202060D0 (en) Novel compounds and methods for their production
IL233446A0 (en) Polymorphic forms of paramphenel
SG11201404616QA (en) Process of producing cyclohexylbenzene
GB201212279D0 (en) Method of construction
SG10201701021XA (en) Method of synthesis